Venmax Drugs & Pharmaceuticals Ltd (531015) — Board Meeting | 31 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved 2025-26 Directors Report, Secretarial Audit, and 37th AGM on September 26, 2026.
🔄 What Changed
Approved 37th AGM date and e-voting schedule; changed Venkata Rao Sadhanala's designation to Managing Director effective March 11, 2026.
🔮 What's Next
37th AGM scheduled for September 26, 2026 via video conference; e-voting from September 23-25, 2026.
💡 Investor Takeaway
Shareholders must approve the Managing Director appointment and new directors at the upcoming AGM.

Venmax Drugs & Pharmaceuticals announced board approval of the 2025-26 Directors Report, Secretarial Audit, and 37th AGM scheduled for September 26, 2026 via video conference, with e-voting from September 23-25 and shareholder record dates set for September 18-26, 2026.

📄 View Original Announcement (PDF)

About Venmax Drugs & Pharmaceuticals Ltd (531015)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹17.88 Cr P/E: 37.7 ROE: -42.4% ROCE: -50.8%

View full 531015 stock details →

📡 Get AI alerts when 531015 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 531015 — Free

📊 More 531015 filings

See all 531015 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day